Chemours Q4 Loss Deepens as Industrial Slump Hits Volumes

The company posted a loss of 31 cents per share, a significant drop from the 8-cent loss recorded during the same period last year. On an adjusted basis, earnings reached 5 cents per share, falling short of the 7-cent consensus forecast provided by FactSet. Management attributed the deepening deficit to under-absorption of costs at its manufacturing facilities and a non-cash inventory charge within its advanced performance materials division.

Revenue slipped 2% to $1.33 billion, matching market expectations despite a 4% decline in overall volume. While price hikes and favorable currency shifts provided a minor 1% buffer each, they were insufficient to counter the cyclical downturn in the company’s titanium technologies business. According to the report, the wider loss was also impacted by a higher provision for income taxes and an unfavorable product mix.

Divergent Segment Performance

Performance across the portfolio remained uneven. While cyclically sensitive end markets dragged down the industrial segments, the Thermal and Specialized Solutions unit provided a strategic bright spot. This growth was fueled by the steady adoption of Opteon refrigerants, which helped mitigate broader volume losses.

Looking ahead, Chemours issued a long-term forecast targeting sales growth of 3% to 5% by 2026. For the full year, the company expects adjusted EBITDA to land between $800 million and $900 million. This guidance aligns closely with Wall Street projections, which currently forecast an average of $878.6 million for the period.